265 related articles for article (PubMed ID: 24269558)
1. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases.
Lin Y; Huang G; Jamison S; Li J; Harding HP; Ron D; Lin W
Am J Pathol; 2014 Feb; 184(2):507-19. PubMed ID: 24269558
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress.
Lin W; Kemper A; Dupree JL; Harding HP; Ron D; Popko B
Brain; 2006 May; 129(Pt 5):1306-18. PubMed ID: 16504972
[TBL] [Abstract][Full Text] [Related]
3. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis.
Lin W; Lin Y; Li J; Fenstermaker AG; Way SW; Clayton B; Jamison S; Harding HP; Ron D; Popko B
J Neurosci; 2013 Apr; 33(14):5980-91. PubMed ID: 23554479
[TBL] [Abstract][Full Text] [Related]
4. Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE.
Yue Y; Stanojlovic M; Lin Y; Karsenty G; Lin W
J Neuroinflammation; 2019 Feb; 16(1):23. PubMed ID: 30709400
[TBL] [Abstract][Full Text] [Related]
5. Genetic inactivation of PERK signaling in mouse oligodendrocytes: normal developmental myelination with increased susceptibility to inflammatory demyelination.
Hussien Y; Cavener DR; Popko B
Glia; 2014 May; 62(5):680-91. PubMed ID: 24481666
[TBL] [Abstract][Full Text] [Related]
6. Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.
Stone S; Wu S; Jamison S; Durose W; Pallais JP; Lin W
Glia; 2018 Jul; 66(7):1331-1345. PubMed ID: 29436030
[TBL] [Abstract][Full Text] [Related]
7. Prolonging the integrated stress response enhances CNS remyelination in an inflammatory environment.
Chen Y; Kunjamma RB; Weiner M; Chan JR; Popko B
Elife; 2021 Mar; 10():. PubMed ID: 33752802
[TBL] [Abstract][Full Text] [Related]
8. NF-κB Activation Accounts for the Cytoprotective Effects of PERK Activation on Oligodendrocytes during EAE.
Lei Z; Yue Y; Stone S; Wu S; Lin W
J Neurosci; 2020 Aug; 40(33):6444-6456. PubMed ID: 32661025
[TBL] [Abstract][Full Text] [Related]
9. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage.
Lin W; Bailey SL; Ho H; Harding HP; Ron D; Miller SD; Popko B
J Clin Invest; 2007 Feb; 117(2):448-56. PubMed ID: 17273557
[TBL] [Abstract][Full Text] [Related]
10. NF-κB Activation Protects Oligodendrocytes against Inflammation.
Stone S; Jamison S; Yue Y; Durose W; Schmidt-Ullrich R; Lin W
J Neurosci; 2017 Sep; 37(38):9332-9344. PubMed ID: 28842413
[TBL] [Abstract][Full Text] [Related]
11. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma.
Lin W; Harding HP; Ron D; Popko B
J Cell Biol; 2005 May; 169(4):603-12. PubMed ID: 15911877
[TBL] [Abstract][Full Text] [Related]
13. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
14. Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders.
Mausner-Fainberg K; Benhamou M; Golan M; Kimelman NB; Danon U; Marom E; Karni A
Neurotherapeutics; 2021 Jul; 18(3):1798-1814. PubMed ID: 34159538
[TBL] [Abstract][Full Text] [Related]
15. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination.
Harrington EP; Zhao C; Fancy SP; Kaing S; Franklin RJ; Rowitch DH
Ann Neurol; 2010 Nov; 68(5):703-16. PubMed ID: 20853437
[TBL] [Abstract][Full Text] [Related]
16. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
17. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
18. The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.
Hussain R; Ghoumari AM; Bielecki B; Steibel J; Boehm N; Liere P; Macklin WB; Kumar N; Habert R; Mhaouty-Kodja S; Tronche F; Sitruk-Ware R; Schumacher M; Ghandour MS
Brain; 2013 Jan; 136(Pt 1):132-46. PubMed ID: 23365095
[TBL] [Abstract][Full Text] [Related]
19. ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases.
Pouzol L; Baumlin N; Sassi A; Tunis M; Marrie J; Vezzali E; Farine H; Mentzel U; Martinic MM
FASEB J; 2021 Mar; 35(3):e21431. PubMed ID: 33595155
[TBL] [Abstract][Full Text] [Related]
20. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
Lemus HN; Warrington AE; Denic A; Wootla B; Rodriguez M
Hum Antibodies; 2017; 25(3-4):121-129. PubMed ID: 28269761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
